Conclusion Idarubicin is the favorable on the compound chemotherapy for the elderly patients with hematologic mal...

• 结论在条件许可时,老年血液肿瘤患者选用含去甲氧柔红霉素的联合化疗,可能具有疗效好、不良反应小的优势。